New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Inogen, Inc.
INGN
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

213M

Medical - Devices

Next Earning date - 05 Nov 2024

213M

Medical - Devices

Next Earning date - 05 Nov 2024

8.99USD
Shape0.09 ( 1.01%)
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

-21%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

33%

Quote Panel

Shape
Updated October 12, 2024
1W -1.86 % 1M -20.65 % 3M -2.18 % 1Y 95.01 %

Key Metrics

Shape
  • Market Cap

    213.23M


  • Shares Outstanding

    23.72M


  • Share in Float

    23.35M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    8.99


  • Average Volume

    208871


  • Beta

    1.042


  • Range

    4.13-13.33


  • Industry

    Medical - Devices


  • Website

    https://www.inogen.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.65x

P/S Ratio

1.12x

P/B Ratio

0.1

Debt/Equity

-28.3%

Net Margin

$-4.0

EPS

How INGN compares to sector?

P/E Ratio

Relative Strength

Shape

INGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$341M

Shape284%

2025-Revenue

$1.68

Shape-602%

2025-EPS

$542K

Shape179%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

William Blair

upgrade

Previous: Not converted

2024-02-15

Now: Outperform

Needham

downgrade

Previous: Not converted

2023-07-14

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.18
vs 0.53

Q4.22

arrow
arrow

N/A

-0.57
vs -1.01

Q1.23

arrow
arrow

N/A

-0.63
vs -0.38

Q2.23

arrow
arrow

N/A

-0.42
vs -0.02

Q3.23

arrow
arrow

N/A

-1.97
vs -0.18

Q4.23

arrow
arrow

N/A

-1.14
vs -0.57

Q1.24

arrow
arrow

N/A

-0.62
vs -0.63

Q2.24

arrow
arrow

N/A

-0.24
vs -0.42

Q3.24

arrow
arrow

N/A

-0.50
vs -1.97

Q4.24

arrow
arrow

N/A

-0.57
vs -1.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+13%

105.4M  vs 93.1M

Q4.22

arrow
arrow

+15%

88.1M  vs 76.4M

Q1.23

arrow
arrow

-10%

72.2M  vs 80.4M

Q2.23

arrow
arrow

-19%

83.6M  vs 103.4M

Q3.23

arrow
arrow

-20%

84M  vs 105.4M

Q4.23

arrow
arrow

-14%

75.9M  vs 88.1M

Q1.24

arrow
arrow

+8%

78M  vs 72.2M

Q2.24

arrow
arrow

+6%

88.8M  vs 83.6M

Q3.24

arrow
arrow

+0%

84.1M  vs 84M

Q4.24

arrow
arrow

+1%

76.6M  vs 75.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.01

Q4.22

arrow
arrow

-19%

-0.19
vs -0.03

Q1.23

arrow
arrow

-7%

-0.07
vs -0.19

Q2.23

arrow
arrow

-4%

-0.04
vs -0.07

Q3.23

arrow
arrow

-20%

-0.20
vs -0.04

Q4.23

arrow
arrow

-13%

-0.13
vs -0.20

Q1.24

arrow
arrow

-8%

-0.08
vs -0.13

Q2.24

arrow
arrow

-3%

-0.03
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

142

142
vs 135

5%

Q4.22

arrow
arrow

134

134
vs 142

-6%

Q1.23

arrow
arrow

154

154
vs 134

15%

Q2.23

arrow
arrow

140

140
vs 154

-9%

Q3.23

arrow
arrow

127

127
vs 140

-9%

Q4.23

arrow
arrow

128

128
vs 127

1%

Q1.24

arrow
arrow

134

134
vs 128

5%

Q2.24

arrow
arrow

132

132
vs 134

-1%

Earnings Growth

Latest News